NRX Pharmaceuticals, Inc. (NRXP)
1.695
-0.08
(-4.24%)
USD |
NASDAQ |
Mar 06, 16:00
1.75
+0.06
(+3.24%)
After-Hours: 20:00
NRX Pharmaceuticals Cash from Investing (Quarterly) : -2.561M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Synergy CHC Corp. | 0.00 |
| Vivos Therapeutics, Inc. | 0.083M |
| Acurx Pharmaceuticals, Inc. | 0.00 |
| NeOnc Technologies Holdings, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.891M |
| Cash from Financing (Quarterly) | 9.726M |
| Free Cash Flow | -11.86M |
| Free Cash Flow Per Share (Quarterly) | -0.13 |
| Free Cash Flow to Equity (Quarterly) | -3.067M |
| Free Cash Flow to Firm (Quarterly) | -2.891M |
| Free Cash Flow Yield | -40.98% |